Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | telomerase reverse transcriptase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Candida albicans | telomerase reverse transcriptase | Get druggable targets OG5_131652 | All targets in OG5_131652 |
Babesia bovis | conserved hypothetical protein | Get druggable targets OG5_131652 | All targets in OG5_131652 |
Candida albicans | telomerase reverse transcriptase | Get druggable targets OG5_131652 | All targets in OG5_131652 |
Theileria parva | hypothetical protein | Get druggable targets OG5_131652 | All targets in OG5_131652 |
Brugia malayi | Telomerase reverse transcriptase | Get druggable targets OG5_131652 | All targets in OG5_131652 |
Onchocerca volvulus | Telomerase reverse transcriptase homolog | Get druggable targets OG5_131652 | All targets in OG5_131652 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | transcription factor LCR-F1 | 0.0037 | 0.0739 | 1 |
Brugia malayi | hypothetical protein | 0.0037 | 0.0739 | 0.0658 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.002 | 0.0284 | 0.1085 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0739 | 1 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.002 | 0.0284 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.0739 | 1 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.002 | 0.0284 | 0.5 |
Leishmania major | telomerase reverse transcriptase, putative | 0.0103 | 0.2533 | 1 |
Entamoeba histolytica | recQ family DNA helicase | 0.001 | 0.0011 | 0.0146 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0739 | 1 |
Treponema pallidum | ATP-dependent DNA helicase | 0.001 | 0.0011 | 0.5 |
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.001 | 0.0011 | 0.0043 |
Entamoeba histolytica | recQ family helicase, putative | 0.002 | 0.0284 | 0.3847 |
Giardia lamblia | Telomerase catalytic subunit | 0.0103 | 0.2533 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 0.0284 | 0.1123 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0011 | 0.00000000841 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 0.0284 | 0.1123 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.002 | 0.0284 | 0.5 |
Schistosoma mansoni | DNA helicase recq5 | 0.002 | 0.0284 | 0.3755 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0037 | 0.0739 | 1 |
Plasmodium vivax | telomerase reverse transcriptase, putative | 0.0103 | 0.2533 | 1 |
Loa Loa (eye worm) | RecQ helicase | 0.002 | 0.0284 | 1 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.002 | 0.0284 | 0.5 |
Trypanosoma brucei | telomerase reverse transcriptase | 0.0103 | 0.2533 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0739 | 1 |
Brugia malayi | Telomerase reverse transcriptase | 0.0273 | 0.7194 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.001 | 0.0011 | 0.0043 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.0103 | 0.2533 | 1 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.0103 | 0.2533 | 1 |
Toxoplasma gondii | RNA-directed DNA polymerase | 0.0103 | 0.2533 | 1 |
Plasmodium falciparum | telomerase reverse transcriptase | 0.0103 | 0.2533 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0037 | 0.0739 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0284 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0739 | 1 |
Schistosoma mansoni | DNA helicase recq1 | 0.002 | 0.0284 | 0.3755 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 14.8 uM | Inhibition of telomerase-mediated supercoiling activity in human MGC803 cells after 24 hrs by TRAP-PCR-ELISA assay | ChEMBL. | 23265905 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.